www.genome-explorations-org.fyu.vlb.mybluehost.me Open in urlscan Pro
162.241.24.53  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Toggle navigation Genome Explorations
 * About
   * About Us
   * Management
   * Scientific Advisory Board
   * Strategic Alliances
 * Contact
 * Clinical
   * Overview of Clinical Services
   * Targeted Cancer MDx
   * Cancer Specific MDx
   * Inherited Disease MDx
 * Research
   * Overview of Research Services
   * Companion Dx & Biomarker Discovery
   * Genotyping Analysis (SNP)
   * Expression Analysis
   * Chromosomal Abnormality (FISH)
 * Bioinformatics
   * Bioinformatics Overview
   * Microarray Analysis
   * NGS Analysis
   * Custom Solutions & Advanced Analysis
 * Pubs & Pats
   * Publications
   * Patents
   * News
   * Awards
 * Data Downloads


A PREMIER RESEARCH INSTITUTION PROVIDING GLOBAL GENOMIC PROFILING AND MOLECULAR
DIAGNOSTICS SERVICES TO ACADEMIC CENTERS, PHARMACEUTICAL AND BIOTECH INDUSTRY,
ONCOLOGISTS, AND PATHOLOGISTS WITH INNOVATIVE DIAGNOSTIC, PROGNOSTIC,
PREDICTIVE, AND PERSONALIZED TESTING.


Clinical Services
Research Services
Bioinformatics Services


 * 
 * 
 * 
 * 


ONE PARTNER. INFINITE SOLUTIONS.

Genome Explorations, Inc. is a premier research institution providing global
genomic profiling and molecular diagnostics services to academic centers,
pharmaceutical and biotech industry, oncologists, and pathologists with
innovative diagnostic, prognostic, predictive, and personalized testing. We
believe that the combination of unparalleled quality diagnostics,
industry-leading innovation, and exceptional service enable us to help a range
of clients develop and implement a personalized approach to healthcare and,
ultimately, eradicate the most malicious disease states.

Genome Explorations Inc. was founded by Dr. Divyen H. Patel to provide Academic,
Biotech and Pharmaceutical institutes with a ‘Complete Solution’ for RNA, miRNA
and DNA analysis. Genome explorations also provide all associated Bioinformatic
solutions to make sence of the data generated through these high through put
technologies. Dr. Patel started and managed the Genomics Core Facility at St.
Jude Children’s Research Hospital. The finding’s from one of the many studies
conducted through his core was described in a seminal study on the cover of
Cancer Cell (Cancer Cell Vol. 1 133-143 March 2002). The study pioneered the use
of global genomics to enhance diagnosis of pediatric leukemia and evaluate
prognostic outcome in patients. The extensive experience gained through working
with scores of investigators, resulting in over a hundred publications, has made
Genome Explorations Inc. the number one choice for Investigators worldwide for
all their genomic projects.

The ‘Complete Solution’ requires you, our client, to only provide us with your
biological samples (DNA, RNA, Cells, Tissue or Blood). Our highly trained staff
subsequently process these samples to completion and analyze them using the
latest advanced bioinformatics solutions. This model, combined with the
one-on-one interactions we have with our investigators, allows us to generate
the highest quality data sets in the industry.




SELECT SERVICES

May 3, 2018 3 min read bioinformatics, microarray, ngs, advanced


CUSTOM SOLUTIONS & ADVANCED ANALYSES

We have the SOLUTIONS to meet your BIOINFORMATICS needs When it comes to
developing custom pipelines, implementing the most cutting edge analyses &
profiling techniques, we work with our clients to ensure their informatics needs
are met. Whether implementing a sofisticated analysis method, designing a custom
analysis pipeline, utilizing cutting-edge machine learning techniques for
biomarker classification, or simply producing publication-ready figures, our
staff combines years of experience with highly qualified personnel to meet your
every need.

CONTINUE READING

May 2, 2018 1 min read services, ngs, microarray, expression, research


EXPRESSION ANALYSIS

Gene Expression Services Scientists at Genome Explorations have worked with over
350 scientists worldwide in meeting their gene expression needs. As an industry
leader in the microarray field and a certified provider of Affymetrix®
microarray services and Life Technologies qPCR services, we have developed a
series of SOPs that allow us to reproducibly generate global gene expression
data sets of the highest quality. Our validated microarray protocols
consistently result in sample-to-sample variability of less than 0.

CONTINUE READING

May 2, 2018 10 min read services, ngs, cancer, clinical, breast, lung, liver,
colorectal, leukemia, ovarian, prostate, gastric, cancer-specific


CANCER SPECIFIC MDX

Detect, Characterize. Genomic research continues to identify mutations
associated with specific cancers and, in combination with clinical research, to
identify their clinical relevance to a specific cancer and the
prognosis/treatment for patients. While some mutations may be pathogenic, some
are benign. Mutation profiling allows us to identify which mutations are
present, determine clinical significance of those mutations, and identify
pathogentic mutations with actionable therapies. To this end, mutation profiling
using next generation sequencing and targeted cancer-specific panels allows us
to detect mutations across multiple genes simultaneously and to screen patient
susceptibility to a specific cancer.

CONTINUE READING


CONTACT

 * tech@genome-explorations.com
 * 901-578-5708
 * 1910 Nonconnah Blvd., Suite 120, Memphis, TN 38132
 * Monday-Friday, 8:30 am to 5:00 pm

Genome Explorations© 2019 · Powered by the Academic theme for Hugo.

×

CITE



Copy Download